Mechanism of efferocytosis in atherosclerosis

Li-Xia Shu1,2, Liu-Li Cao1,2, Xin Guo1,2

  • 1Institute of Pharmacy and Pharmacology, School of Pharmaceutical Sciences, Hengyang Medical School, University of South China, Hengyang, 421001, China.

Journal of Molecular Medicine (Berlin, Germany)
|May 10, 2024
PubMed

Insights

Macrophages normally clear dead cells in atherosclerosis (AS). Impaired efferocytosis and CD47 upregulation in advanced AS lead to cell buildup, worsening the disease and necrotic core expansion.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cellular Biology

Background:

  • Atherosclerosis (AS) is a chronic inflammatory vascular disease linked to cardiovascular morbidity and mortality.
  • Abnormal cell proliferation and accumulation drive AS plaque expansion, necrotic core formation, and rupture.
  • Macrophages play a critical role in regulating AS through efferocytosis, the process of clearing apoptotic and necrotic cells.

Purpose of the Study:

  • To review the molecular mechanisms of efferocytosis in atherosclerosis.
  • To discuss how efferocytosis becomes impaired during AS progression.
  • To explore regulatory mechanisms of efferocytosis for potential therapeutic insights.

Main Methods:

  • Literature review of molecular mechanisms in efferocytosis.
  • Analysis of macrophage function and efferocytosis in early versus advanced AS.
  • Examination of CD47's role in protecting apoptotic cells from phagocytosis.

Main Results:

  • In early AS, macrophages effectively clear apoptotic cells (ACs) via efferocytosis, slowing disease progression.
  • In advanced AS, macrophage efferocytosis is impaired, leading to delayed AC removal.
  • Upregulated CD47 on AS plaques inhibits macrophage phagocytosis of ACs, expanding the necrotic core.

Conclusions:

  • Impaired efferocytosis and CD47 upregulation are key factors in AS exacerbation.
  • Understanding these mechanisms offers potential targets for novel AS treatments.
  • Restoring efferocytosis may be a promising therapeutic strategy for atherosclerosis.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
53.4K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
104.4K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.8K
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
453
Recycling Endosomes and Transcytosis00:58

Recycling Endosomes and Transcytosis

The recycling endosome, also known as the endosomal recycling compartment (ERC), is a part of the slow-recycling process of the endocytic pathway. Molecules internalized through receptor-mediated endocytosis are either degraded in the lysosomes or are recycled to the plasma membrane through the fast- or slow-recycling route.
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
2.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K